Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported holding around 4.5 million shares of the company, up from some 3.6 million held at the end of September. The stake is passive by nature and amasses 5.1% of the company’s common stock.

Kevin Kotler

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a clinical-stage drug development company. Earlier in October, the company provided updated regarding two of its pipeline products: R333 and Fostamatinib. The first drug, developed as a therapeutic for skin lesions for patients with discoid lupus erythematosus, did not meet the expectations in the Phase 2 clinical study, the company said in a statement. Rigel also conducted a meeting with FDA regarding the Phase 2 of fostamatinib, a drug for patients with immune thrombocytopenic purpura. The company plans to move on to Phase 3 studies during the next year.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has also attracted some other hedge funds, which revealed ownership of shares in the latest round of 13F filings.William Leland Edwards Palo Alto Investors, owns, so far, the largest position, with 6.30 million shares, valued at $22.55 million; Millennium Management, managed by Israel Englander holds 2.89 million shares valued at $10.35 million. The fourth hedge fund with the largest stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is D E Shaw’s D. E. Shaw, which holds 1.09 million shares which is valued at $3.92 million.

Broadfin Capital invests primarily in the healthcare sector, with smaller interest in the services and other sectors.

In the last quarter, Broadfin Capital reported movement in some other companies, in addition to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL):  Horizon Pharma Inc (NASDAQ:HZNP) and Alliqua Inc (OTCMKTS:ALQA). In Horizon Pharma Inc, the fund has moved to 3.9 million shares from its earlier 1.9 million shares, holding 5.9% of the company’s stock. In Alliqua Inc it holds 774,400 as shares, which is 7.8% of the common stock. Also, the fund has increased its position in Derma Sciences Inc (NASDAQ:DSCI) moving from 771,600 shares to 871,600 shares.

Disclosure: none

Recommended Reading:

Oz Management Reveals New Stake in American Airlines Group Inc (AAL)

Mario Gabelli, GAMCO Investors’ Latest Moves Involve Communications Systems, Inc. (JCS), Lawson Products, Inc. (LAWS) & More

Ken Griffin, Citadel Raise Exposure to Monolithic Power Systems, Inc. (MPWR), and AMC Entertainment Holdings Inc (AMC)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!